Celsius Holdings, Inc. Common Stock
CELH
$32.99
-6.36%
Celsius Holdings, Inc. is a consumer defensive company operating in the non-alcoholic beverage industry, specializing in energy drinks. It owns three brands—Celsius, Alani Nu, and Rockstar Energy—and generates 95% of its revenue in North America, leveraging a capital-light model with outsourced manufacturing and distribution through PepsiCo. The company has transformed into a multi-brand growth platform, with the Alani Nu acquisition driving recent revenue growth, but it faces intense competition and slowing momentum in its flagship Celsius brand, as evidenced by a recent Q2 miss and a sharp one-day stock drop. Investor attention is focused on whether the company can reignite growth in its core brand while integrating new acquisitions and navigating a challenging competitive landscape.…
CELH
Celsius Holdings, Inc. Common Stock
$32.99
Related headlines
Investment Opinion: Should I buy CELH Today?
We rate CELH as a Buy, driven by the transformative Alani Nu acquisition that has created a multi-brand growth platform with significant revenue acceleration. The consensus analyst rating is Buy (1.70 mean) with an average target of $40.95, implying 22.8% upside. The forward PE of 19.16x is attractive relative to the trailing PE of 182.96x, suggesting the market expects substantial earnings growth. Revenue growth of 137.7% YoY in Q1 2026 and a net margin of 14.1% demonstrate the earnings power of the combined business. The balance sheet is solid with a debt-to-equity of 0.23, and the PS ratio of 4.28x is below the industry average of 5.5x, indicating a potential valuation discount.
Sign up to view all
CELH 12-Month Price Forecast
The AI assessment leans bullish due to the compelling growth narrative and attractive forward valuation. The Alani Nu acquisition has transformed the company, and the market appears to be pricing in conservative expectations. However, the medium confidence reflects the uncertainty around the core brand's momentum and competitive pressures. If the company can demonstrate sustained growth and margin stability, the stock could re-rate significantly higher. Conversely, any signs of deceleration would warrant a downgrade to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Celsius Holdings, Inc. Common Stock's 12-month outlook, with a consensus price target around $42.05 and implied upside of +27.5% versus the current price.
Average Target
$42.05
0 analysts
Implied Upside
+27.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$26 - $64
Analyst target range
Analyst coverage is robust with 20 analysts, and the consensus recommendation is 'Buy' (mean rating of 1.70). The average target price is $40.95, implying +22.8% upside from the current price of $33.36. The target range is $26.00 to $56.00, with the low target suggesting a 22% downside and the high target implying a 68% upside. Recent ratings have been overwhelmingly positive, with firms like Citigroup, Needham, and UBS reiterating Buy ratings in July 2026, indicating sustained bullish sentiment despite the stock's decline. The wide target spread reflects high uncertainty about the company's growth trajectory and competitive position.
Bulls vs Bears: CELH Investment Factors
Celsius presents a classic high-growth turnaround story with significant upside potential, but it is clouded by execution risks and competitive pressures. The bull case is anchored by the transformative Alani Nu acquisition, which has driven explosive revenue growth and restored profitability, while the bear case highlights the deceleration in the core Celsius brand and volatile cash flows. Currently, the evidence slightly favors the bulls given the strong analyst support and attractive forward valuation, but the key tension is whether the company can reignite growth in its flagship brand while successfully integrating acquisitions. If Celsius brand sales stabilize and the multi-brand strategy gains traction, the stock could re-rate higher; conversely, continued share losses would undermine the entire thesis.
Bullish
- Explosive Revenue Growth from Alani Nu: Q1 2026 revenue surged 137.7% YoY to $782.6M, driven by the Alani Nu acquisition, transforming Celsius into a multi-brand platform. This scale provides significant operating leverage and diversification beyond the flagship Celsius brand.
- Strong Profitability Recovery: Net income swung to $110.1M in Q1 2026 (14.1% net margin) from a loss in Q3 2025, with gross margin expanding to 48.3%. This demonstrates the earnings power of the combined portfolio and supports the low forward PE of 19.16x.
- Solid Balance Sheet with Low Debt: Debt-to-equity is a conservative 0.23, and the current ratio of 1.68 indicates ample liquidity. This financial flexibility supports continued investment in brand marketing and potential acquisitions.
- Analyst Consensus is Buy with 22.8% Upside: With 20 analysts, the mean rating is 1.70 (Buy) and the average target price is $40.95, implying 22.8% upside from $33.36. Recent reiterations from Citigroup, Needham, and UBS in July 2026 signal sustained institutional confidence.
Bearish
- Declining Flagship Brand Momentum: The Q2 2026 earnings miss and a one-day 18% stock drop highlight slowing sales for the core Celsius brand. This raises questions about the sustainability of growth beyond the Alani Nu acquisition.
- Erratic Sequential Revenue Trends: Revenue plateaued between Q3 2025 ($725.1M) and Q4 2025 ($721.6M) before jumping in Q1 2026, indicating inconsistent demand. This volatility complicates forecasting and may signal market share challenges.
- Negative Free Cash Flow in Q4 2025: FCF turned negative at -$130.0M in Q4 2025, reflecting heavy investment and working capital swings. Although it recovered to $65.8M in Q1 2026, the volatility suggests cash generation is not yet stable.
- Intense Competition from Monster and Red Bull: The energy drink market is fiercely competitive, with Monster and Red Bull holding dominant positions. Celsius's market share gains may be difficult to sustain, especially as competitors innovate and increase marketing spend.
CELH Technical Analysis
CELH is in a pronounced downtrend over the past year, with a 1-year price change of -46.25%, significantly underperforming the S&P 500's +20.48% gain. The current price of $33.36 sits at 24.6% of its 52-week range (between $23.56 low and $66.74 high), indicating the stock is near the lower end of its yearly range, which often suggests either a value opportunity or a falling knife. The stock has been range-bound between roughly $27 and $33 over the past three months, with a 3-month change of +10.76%, but the longer-term trend remains bearish.
Beta
0.92
0.92x market volatility
Max Drawdown
-63.4%
Largest decline past year
52-Week Range
$24-$67
Price range past year
Annual Return
-44.8%
Cumulative gain past year
| Period | CELH Return | S&P 500 |
|---|---|---|
| 1m | +12.0% | +4.1% |
| 3m | -0.8% | +1.9% |
| 6m | -38.5% | +12.4% |
| 1y | -44.8% | +19.3% |
| ytd | -30.9% | +13.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CELH Fundamental Analysis
Revenue growth has been erratic but recently accelerated: Q1 2026 revenue was $782.6 million, up 137.7% YoY from $329.3 million in Q1 2025, driven by the Alani Nu acquisition. However, sequential growth has been inconsistent, with Q4 2025 revenue of $721.6 million and Q3 2025 revenue of $725.1 million, indicating a plateau. The company's net income swung to $110.1 million in Q1 2026 (net margin of 14.1%) from a loss of $61.0 million in Q3 2025, but profitability remains volatile. Gross margin improved to 48.3% in Q1 2026 from 47.4% in Q4 2025, but operating margin compressed to 17.8% from 19.3% in Q2 2025, reflecting increased SG&A spending. The balance sheet is solid with a current ratio of 1.68 and a low debt-to-equity ratio of 0.23, but free cash flow turned negative in Q4 2025 (-$130.0 million) before recovering to $65.8 million in Q1 2026, indicating cash flow volatility.
Quarterly Revenue
$782615000.0B
2026-03
Revenue YoY Growth
+137.7%
YoY Comparison
Gross Margin
48.3%
Latest Quarter
Free Cash Flow
$292759000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CELH Overvalued?
Given positive net income, the PE ratio is the primary metric: trailing PE is 182.96x, while forward PE is 19.16x, implying the market expects a dramatic earnings increase (likely from the Alani Nu acquisition). The PS ratio of 4.28x is below the industry average of 5.5x (if available), suggesting a discount to peers. Historically, the stock's PE has ranged from -93x to 285x over the past two years, with the current trailing PE near the higher end, but the forward PE is near the lower end, indicating the market is pricing in optimistic growth expectations.
PE
183.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 27x~153x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
54.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Celsius faces risks from its erratic profitability and cash flow. Net income swung from a loss of $61.0M in Q3 2025 to a profit of $110.1M in Q1 2026, but this volatility makes earnings quality questionable. Free cash flow turned negative in Q4 2025 (-$130.0M) before recovering, indicating that the company's capital-light model still requires significant working capital investment. The high trailing PE of 182.96x means that any earnings miss could trigger a sharp de-rating, as seen in the 18% one-day drop after Q2 2026. Additionally, the company's reliance on PepsiCo for distribution and the integration of Alani Nu add operational complexity that could strain margins if not managed well.